Surveillance, Fear, and Alleged Sexual Harassment at Hedge Fund Bridgewater | Connecticut Public Radio
WNPR

Surveillance, Fear, and Alleged Sexual Harassment at Hedge Fund Bridgewater

Jul 27, 2016

A complaint filed with the Connecticut Commission on Human Rights and Opportunities, and later withdrawn, described a culture of surveillance and fear at Bridgewater Associates in Westport

The New York Times reported that an investment advisor alleged he was sexually harassed by a supervisor, and after complaining, pressured by top managers at Bridgewater to rescind the complaint. 

The Times spoke with seven former employees or people who had worked for the world's largest hedge fund. They described the level of secrecy at the firm.  

Bridgewater founder Ray Dalio has said one of Bridgewater's foundational principles is transparency around employee grievances and concerns.

Bridgewater did not respond to WNPR's request for comment.

Pfizer Complains of Its Drug Being Used in Arkansas Executions

It appears Arkansas obtained a paralytic drug made by a subsidiary of Pfizer for use in its executions. That’s according to a report from the Associated Press.

Pfizer, whose research headquarters are in Groton, has said it doesn't want its drugs used that way, and that it has safeguards in place to prevent such use.

Last year, Arkansas legislators passed a secrecy law to keep most of the state’s lethal injection policy a secret, saying firms needed to be protected from protests or boycotts.

The legislator who drafted the law said on Tuesday that companies have no standing to complain that their drugs will be used in executions, and that Pfizer could only complain to the third-party vendor that sold the drug to the state.